 |
|
Do NMDA Antagonists Prevent Neuronal Injury? Yes.
Gregory W. Albers, MD;
Mark P. Goldberg, MD;
Dennis W. Choi, MD, PhD
Arch Neurol. 1992;49(4):418-420.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Available evidence suggests that pharmacologic antagonism of the N-methyl-d-aspartate (NMDA) receptor can reduce neuronal death following hypoxic-ischemic insults. This evidence is derived from experimental models, as clinical trials have not yet been completed. The observed neuroprotective effects of NMDA antagonists do not represent isolated findings, but rather they are predictions of a strong hypothesis implicating excitotoxicity—the lethal overstimulation of neuronal glutamate receptors1,2—in the pathogenesis of hypoxicischemic central neuronal degeneration.
The excitotoxicity hypothesis has received independent support from microdialysis measurements,3,4 which indicate that during hypoxia-ischemia, extracellular glutamate levels can rise to neurotoxic concentrations.5,6 Other supporting observations include reduced hypoxic neuronal injury following excitatory pathway deafferentation, morphologic similarities between hypoxic injury and excitotoxic injury, and the prominence of neuronal calcium overload in the pathogenesis of both conditions.2,7,8 Although glutamate activates several receptor subtypes, the NMDA subtype may play a critical role in mediating the rapidly triggered
. . . [Full Text PDF of this Article]
Author Affiliations
From the Department of Neurology and Neurological Sciences, Stanford (Calif) Medical School. Dr Choi is now with the Department of Neurology, Washington University School of Medicine, St Louis, Mo.
Footnotes
Accepted for publication September 5, 1991.
Reprint requests to Department of Neurology, Box 811, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110 (Dr Choi).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
